With 88 million of prediabetics estimated by the CDC, of which 80% will turn diabetic within 5 to 10 years if nothing is done, the prevention of diabetes is a strong concern in the US
Ingredia has launched Pep2Dia, an inhibitor of the alpha-glucosidase enzyme designed to help with the reduction of post-meal glycemia peak, and consequently with maintaining healthy blood sugar levels.
Following a NDI status obtained in February, Ingredia has notified to FDA two structure function claims for the ingredient:
With 88 million of prediabetics estimated by the CDC, of which 80% will turn diabetic within 5 to 10 years if nothing is done, the prevention of diabetes is a strong concern in the US.
Reaching this stage of worrying blood sugar levels can happen quite easily after 40 years old, Ingredia says, especially with a family history of diabetes, obesity, a lack of physical activity and/or an unbalanced diet challenging your pancreas function.
